中文产业新闻精选评分66Chinese source
FDA 批准 Ultragenyx 基因疗法 rebisufligene etisparvovec 用于 MPS IIIA 儿童患者
FDA批准突破性基因疗法
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
FDA批准突破性基因疗法
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.